Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT05300360
Eligibility Criteria:
Inclusion Criteria:
1. Signing of the written informed consent form by the patient and/or his legal representative,
2. The patient should be between the ages of 18 and 70,
3. Diagnosis of PAP: The patient has been diagnosed with PAP clinically or histologically.
Exclusion Criteria:
* The patient was diagnosed with ADA enzyme deficiency before being included in the study,
* The patient's PAP diagnosis is secondary to an occupational disease such as silicosis,
* The patient's PAP diagnosis is secondary to an oncological disease,
* The patient has participated in an interventional clinical trial within the last 30 days,
* The patient himself and/or his legal representative did not give their consent to participate in the study,
* According to the researcher's opinion, the patient will not be able to properly fulfill the study requirements,
\* Pregnancy and/or lactation period,
* The fact that the volunteer participating in the study received an erythrocyte suspension or a complete blood transfusion within the last 3 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT05300360
Study Brief:
Protocol Section:
NCT05300360